Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-040836
Filing Date
2024-09-11
Accepted
2024-09-11 16:05:35
Documents
2
Period of Report
2024-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1417
2 EXHIBIT 24 ef20035751_ex24.htm EX-24 7461
  Complete submission text file 0001140361-24-040836.txt   10396
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 GIRALDA FARMS MADISON NJ 07940
Business Address
Dolsten Mikael (Reporting) CIK: 0001437590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 241292651